Abstract

Biliary cysts in adult patients affected by polycystic liver disease are lined by cholangiocytes that proliferate, suggesting that initiation of cyst formation depends on proliferation. Here, we challenge this view by analyzing cyst-lining cell proliferation and differentiation in Cpk mouse embryos and in livers from human fetuses affected by Autosomal Recessive Polycystic Kidney Disease (ARPKD), at early stages of cyst formation. Proliferation of fetal cholangiocyte precursors, measured by immunostaining in human and mouse livers, was low and did not differ between normal and ARPKD or Cpk livers, excluding excessive proliferation as an initiating cause of liver cysts. Instead, our analyses provide evidence that the polycystic livers exhibit increased and accelerated differentiation of hepatoblasts into cholangiocyte precursors, eventually coalescing into large biliary cysts. Lineage tracing experiments, performed in mouse embryos, indicated that the cholangiocyte precursors in Cpk mice generate cholangiocytes and periportal hepatocytes, like in wild-type animals. Therefore, contrary to current belief, cyst formation in polycystic liver disease does not necessarily depend on overproliferation. Combining our prenatal data with available data from adult livers, we propose that polycystic liver can be initiated by proliferation-independent mechanisms at a fetal stage, followed by postnatal proliferation-dependent cyst expansion.

Highlights

  • Polycystic disease of the liver is characterized by the presence of biliary cysts leading to hepatomegaly

  • Developing biliary cells do not proliferate in two models of polycystic liver Human fetuses affected by Autosomal Recessive Polycystic Kidney Disease (ARPKD) develop cysts around the portal vein, which is consistent with a ductal plate origin [23]

  • In many instances the ductal plate was almost entirely cystic from 13 weeks of gestation (13W) onwards, suggesting that most cholangiocytes in the ductal plate are involved in cyst formation (Fig 1A)

Read more

Summary

Introduction

Polycystic disease of the liver is characterized by the presence of biliary cysts leading to hepatomegaly. It is found in patients with polycystic kidney disease—both the autosomal dominant and recessive forms—but when associated with mutations in the Protein kinase C substrate 80K-H, SEC63 or Low density lipoprotein receptor-related protein 5 genes, it presents as an isolated liver disease. Liver cysts are found in syndromes that are collectively characterized by dysfunction of primary cilia [1, 2]. Autosomal Recessive Polycystic Kidney Disease (ARPKD) is caused by mutations in PKHD1, which codes for PLOS ONE | DOI:10.1371/journal.pone.0132295. Autosomal Recessive Polycystic Kidney Disease (ARPKD) is caused by mutations in PKHD1, which codes for PLOS ONE | DOI:10.1371/journal.pone.0132295 June 30, 2015

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call